NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/02/2026
Back to search
Official data from USPTO
BEONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BEONE
ST13
US500000098746778Class
5, 40, 42, 44
Filing
98746778
Registration
8287144
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
06/02/2026
Trademark type
Word
Nice classes
5, 40, 42, 44
Filing date
09/12/2024
Registration date
06/02/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/14/2025
First use in commerce
11/14/2025
Drawing code
4
Owner type
16
Owner location
BASEL, CH
Examiner
QUEEN, ESTHER FELICIA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BEONE MEDICINES I GMBH
BeiGene Switzerland GMBH
Representatives
Kristen Ruisi Venable LLP
Technical classification
Nice Classes
Class 5Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases
Class 40
Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases
Class 42
Research and development of new products for others; technological research in the field of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; electronic data storage; material testing
Class 44
Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advicepharmaceutical advice
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/10/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/10/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/28/2026
IUAF
USE AMENDMENT FILED
12/04/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/04/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/10/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/09/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
04/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/17/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/17/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/17/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/17/2025
DOCK
ASSIGNED TO EXAMINER
03/12/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/24/2025
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
09/16/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/16/2024
NWAP
NEW APPLICATION ENTERED
09/12/2024
Continuous trademark protection
Get notified about every new filing that threatens BEONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.